NCT00946491View on ClinicalTrials.gov

To Demonstrate the Relative Bioequivalency of Generic Haloperidol Tablets Versus Haldol in Normal Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

April 30, 1987

Primary Completion Date

May 31, 1987

Study Completion Date

May 31, 1987

Conditions
Psychosis
Interventions
DRUG

Haloperidol 10 mg Tablets (Cord Laboratories)

DRUG

Haldol 10 mg Tablets (McNeil Pharmaceuticals)

Sponsors

Lead Sponsor

Sandoz
All Listed Sponsors
lead

Sandoz

INDUSTRY

NCT00946491 - To Demonstrate the Relative Bioequivalency of Generic Haloperidol Tablets Versus Haldol in Normal Volunteers | Biotech Hunter | Biotech Hunter